Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL6604735

CCCn1ccc2ccc3cccnc3c21.N

nearest known ligand 0.66

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 4/20 0.66
HTR2C P28335 4/20 0.66
HTR2B P41595 3/20 0.66
CCR1 P32246 3/20 0.44
CCR5 P51681 3/20 0.44
CCR8 P51685 3/20 0.44
LMNA P02545 3/20 0.44
KDM4E B2RXH2 2/20 0.44
MAPT P10636 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
GMNN O75496 1/20 0.44
TP53 P04637 1/20 0.44
HSP90AA1 P07900 1/20 0.44
MMP2 P08253 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
MMP9 P14780 1/20 0.44
ALOX15 P16050 1/20 0.44
TSHR P16473 1/20 0.44
NFKB1 P19838 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL6603622 0.79 HTR2A (0.67) HTR2AHTR2CHTR2BLMNAKDM4E
SCHEMBL6604727 0.79 HTR2C (1.00) HTR2AHTR2CHTR2BCCR1CCR5
Hydrochloric Acid SCHEMBL6607986 0.78 HTR2A (0.66) HTR2AHTR2CHTR2BLMNAKDM4E
SCHEMBL7771626 0.76 MTNR1A (0.60) HTR2AHTR2CHTR2BMTNR1AL3MBTL1
Ammonia Solution, Strong SCHEMBL906126 0.75 HTR2A (0.70) HTR2AHTR2CHTR2BCCR1CCR8
SCHEMBL27252002 0.70 HTR2A (0.48) HTR2AHTR2CHTR2BCCR1CCR5
SCHEMBL28990232 0.69 BACE1 (0.46) GRM2
SCHEMBL12384269 0.69 SLC6A4 (0.39) HTR2AHTR2CGRM2
SCHEMBL809908 0.68 LMNA (0.50) HTR2AHTR2CHTR2BCCR1CCR5
Phenanthroline SCHEMBL34468931 0.68 CCR1 (0.94) CCR1CCR5CCR8LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1109809-B1 PYRROLOQUINOLINES FOR TREATMENT OF OBESITY CEREBRUS PHARM LTD (GB) 2004-11-17 EP disclosed
US-6365598-B1 FOR THERAPY AND PROPHYLAXIS OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM; DAMAGE TO THE CENTRAL NERVOUS SYSTEM; CARDIOVASCULAR DISORDERS; GASTROINTESTINAL DISORDERS; DIABETES INSIPIDUS; AND SLEEP APNEA VERNALIS RESEARCH LIMITED (GB) 2002-04-02 US disclosed